These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19096147)

  • 1. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
    Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
    Carvalho B; Sillars-Hardebol AH; Postma C; Mongera S; Terhaar Sive Droste J; Obulkasim A; van de Wiel M; van Criekinge W; Ylstra B; Fijneman RJ; Meijer GA
    Cell Oncol (Dordr); 2012 Feb; 35(1):53-63. PubMed ID: 22278361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.
    Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Valcz G; Leiszter K; Molnár B; Tulassay Z
    Pathol Oncol Res; 2011 Sep; 17(3):503-9. PubMed ID: 21267688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [mRNA expression analysis and classification of colonic biopsy samples using oligonucleotide and cDNA microarray techniques].
    Galamb O
    Orv Hetil; 2008 Jul; 149(29):1373-7. PubMed ID: 18617470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
    Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
    Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.
    Galamb O; Spisák S; Sipos F; Tóth K; Solymosi N; Wichmann B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Br J Cancer; 2010 Feb; 102(4):765-73. PubMed ID: 20087348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
    Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of m
    Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
    Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.
    Valcz G; Sipos F; Krenács T; Molnár J; Patai AV; Leiszter K; Tóth K; Solymosi N; Galamb O; Molnár B; Tulassay Z
    Pathol Oncol Res; 2010 Dec; 16(4):541-5. PubMed ID: 20349162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive look at transcription factor gene expression changes in colorectal adenomas.
    Vonlanthen J; Okoniewski MJ; Menigatti M; Cattaneo E; Pellegrini-Ochsner D; Haider R; Jiricny J; Staiano T; Buffoli F; Marra G
    BMC Cancer; 2014 Jan; 14():46. PubMed ID: 24472434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens.
    Nagy ZB; Wichmann B; Kalmár A; Galamb O; Barták BK; Spisák S; Tulassay Z; Molnár B
    Clin Epigenetics; 2017; 9():22. PubMed ID: 28289479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
    Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
    Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional mRNA expression analysis and classification of colonic biopsy samples using overall cDNA microarray technique].
    Galamb O; Sipos F; Dinya E; Spisák S; Somorácz A; Molnár B; Tulassay Z
    Orv Hetil; 2008 Feb; 149(5):219-32. PubMed ID: 18218589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer.
    Liu AY; Liu DG; Du YJ; Pei FH; Yang G; Liu BR; Zhang HT; Wang XH; Fan YJ; Chen YZ; Jiang Y; Chen J
    Cancer Biol Ther; 2014 May; 15(5):489-95. PubMed ID: 24521741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
    Komor MA; de Wit M; van den Berg J; Martens de Kemp SR; Delis-van Diemen PM; Bolijn AS; Tijssen M; Schelfhorst T; Piersma SR; Chiasserini D; Sanders J; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; Carvalho B; Meijer GA; Jimenez CR; Fijneman RJA;
    Int J Cancer; 2020 Apr; 146(7):1979-1992. PubMed ID: 31411736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.